Financial statements Medicofarma Biotech

Balance sheet of Medicofarma Biotech

Company age:
Age:
17 y. 4 m. 25 d.
Share capital:
Share capital:
500 000 PLN
Profit and loss statement Balance Cash flow Profitability

Balance sheet data of MEDICOFARMA BIOTECH

Year
2018
2019
2020
2021
2022
2023
Total assets 1 639 210,18 1 387 848,77 396 176,62 16 768 244,23 16 370 015,23 14 971 548,99
A. Fixed assets 284 490,14 200 017,32 0,00 14 685 690,92 14 106 766,74 12 449 265,27
B. Current assets 1 345 811,29 1 178 922,70 387 267,87 2 082 553,31 2 263 248,49 2 522 283,72
C. Share capital contributions (basic funds) - - - - - 0,00
D. Own shares (stocks) 8 908,75 8 908,75 8 908,75 0,00 - 0,00
Total liabilities 1 639 210,18 1 387 848,77 396 176,62 16 768 244,23 16 370 015,23 14 971 548,99
A. Equity 1 032 122,45 687 260,00 -228 672,61 14 203 681,16 12 614 308,69 9 175 048,55
B. Liabilities and provisions for liabilities 607 087,73 700 588,77 624 849,23 2 564 563,07 3 755 706,54 5 796 500,44
I. Long-term liabilities 0,00 0,00 0,00 - 0,00 1 390 766,30
II. Short-term liabilities 567 810,73 682 128,87 624 849,23 1 688 359,30 2 228 399,73 1 842 738,29
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.